Fennec Pharma Q3 product sales rise 56% on PEDMARK demand
Fennec Pharma Q3 product sales rise 56% on PEDMARK demand Overview US specialty pharma firm's Q3 pro
Fennec Pharma Q3 product sales rise 56% on PEDMARK demand Overview US specialty pharma firm's Q3 pro